Pharmacological management of constipation

被引：51
作者：
Emmanuel, A. V. [1 ]
Tack, J. [2 ]
Quigley, E. M. [3 ]
Talley, N. J. [4 ]
机构：
[1] Univ Coll Hosp, Physiol Unit, London NW1 2BU, England
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Natl Univ Ireland, Dept Med, Cork, Ireland
[4] Mayo Clin, Jacksonville, FL 32224 USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2009年 / 21卷
关键词：
laxatives; prokinetics; probiotics; serotonin; opioids; IRRITABLE-BOWEL-SYNDROME; CHLORIDE CHANNEL ACTIVATOR; RECEPTOR PARTIAL AGONIST; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; OPIOID-INDUCED CONSTIPATION; RANDOMIZED CONTROLLED-TRIAL; BALANCED SOLUTION PMF-100; MORPHINE-INDUCED DELAY; PAM-OR ANTAGONIST;
D O I：
10.1111/j.1365-2982.2009.01403.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P>The approach of this review is to give a pragmatic approach to using laxatives, based on a combination of what is known about mechanism of action and the available literature on evidence.
引用
收藏
页码：41 / 54
页数：14
相关论文
共 155 条
[1]   Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation [J].
Agrawal, A. ;
Houghton, L. A. ;
Morris, J. ;
Reilly, B. ;
Guyonnet, D. ;
Feuillerat, N. Goupil ;
Schlumberger, A. ;
Jakob, S. ;
Whorwell, P. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) :104-114
[2]   Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity:: a possible action through interaction with epithelial cell cytoskeleton contraction [J].
Ait-Belgnaoui, A. ;
Han, W. ;
Lamine, F. ;
Eutamene, H. ;
Fioramonti, J. ;
Bueno, L. ;
Theodorou, V. .
GUT, 2006, 55 (08) :1090-1094
[3]  
Amenta Michele, 2006, Acta Biomed, V77, P157
[4]  
ANDERSON AS, 1985, HUM NUTR-APPL NUTR, V39A, P202
[5]  
ANDORSKY RI, 1990, AM J GASTROENTEROL, V85, P261
[6]  
Andres De Paula Juan, 2008, Acta Gastroenterologica Latinoamericana, V38, P16
[7]  
ANDRESEN V, 2007, GASTROENTEROLOGY, V33, P61
[8]  
[Anonymous], 2005, AM J GASTROENTEROL, V100, pS1, DOI [10.1111/j.1572-0241.2005.50613_1.x, DOI 10.1111/J.1572-0241.2005.50613_1.X]
[9]  
Ashraf W, 1995, ALIMENT PHARM THER, V9, P639, DOI 10.1111/j.1365-2036.1995.tb00433.x
[10]  
Ashraf W, 1996, AM J GASTROENTEROL, V91, P26
12345678910